Gomez-Escandon Felipe J MD is categorized under Physicians Offices in Mission, TX and active since 2007.
Gomez-Escandon Felipe J MD was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Felipe Gomez-Escandon at the company’s single location by writing to 1605 East Expressway 83 # D, Mission, Texas TX 78572 or by phoning (956) 583-2121. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Gomez-Escandon Felipe J MD |
| Contact Person: | Felipe Gomez-Escandon |
| Address: | 1605 East Expressway 83 # D, Mission, Texas 78572 |
| Phone Number: | (956) 583-2121 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physicians Offices |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Gomez-Escandon Felipe J MD was started in 2007 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Felipe Gomez-Escandon for inquiries that concern Gomez-Escandon Felipe J MD by calling the company number (956) 583-2121, as your correspondence is most welcome. Additionally, the physical location of the single location of Gomez-Escandon Felipe J MD can be found at the coordinates 26.1981,-98.30254 as well as the street address 1605 East Expressway 83 # D in Mission, Texas 78572.
For its online presence, you may visit Gomez-Escandon Felipe J MD’s website at and engage with its social media outlets through on Twitter and on Facebook.